Literature DB >> 30054674

Alcohol-induced conditioned place preference negatively correlates with anxiety-like behavior in adolescent mice: inhibition by a neurokinin-1 receptor antagonist.

Hui Huang1,2, Xiaojie Zhang1, Xiaoya Fu1, Xiangyang Zhang3, Bing Lang1, Xiaojun Xiang4, Wei Hao5.   

Abstract

RATIONALE: Although alcohol use disorder and anxiety disorders are highly comorbid in humans, controversy remains regarding whether anxiety predisposes individuals to alcohol reward, and the relationship with neurokinin-1 receptor (NK1R) is unclear.
OBJECTIVES: The objectives of the study are to investigate the association between anxiety-like behavior and alcohol-induced conditioned place preference (CPP) and to examine the effect of NK1R antagonist L-703,606 on this preference and levels of NK1R protein in different brain regions in adolescent mice.
METHODS: The anxiety-like behavior of adolescent male C57BL/6 mice was assessed using the elevated plus maze (EPM) test, and the animals were then allocated into high-anxiety mouse (HAM) and low-anxiety mouse (LAM) groups based on the percent of open arm time (OT%). After the reinforcement of ethanol was established by alcohol-induced CPP (2 g/kg), NK1R expression was quantified in the hippocampus, prefrontal cortex, and amygdala. Finally, the effect of L-703,606 (10 mg/kg) on the alcohol-induced CPP was examined.
RESULTS: LAM showed a greater ethanol preference (P = 0.004) and a higher level of NK1R protein in the hippocampus (P = 0.026) than HAM group. Interestingly, the CPP score positively correlated with OT% (r = 0.520, P = 0.016) and the level of NK1R protein (r = 0.476, P = 0.029) in the hippocampus. Moreover, L-703,606 attenuated alcohol-induced CPP (P < 0.001) in both groups.
CONCLUSIONS: The present results highlight the negative correlation between anxiety-like behavior and the propensity for alcohol and the critical role for NK1R in alcohol reward in adolescent mice. Importantly, the NK1R antagonist L-703,606 might be a promising therapeutic target for alcohol use disorder.

Entities:  

Keywords:  Alcohol use disorder; Anxiety; Conditioned place preference; Neurokinin-1 receptor

Mesh:

Substances:

Year:  2018        PMID: 30054674     DOI: 10.1007/s00213-018-4976-7

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  64 in total

Review 1.  Conditioned place preference: what does it add to our preclinical understanding of drug reward?

Authors:  M T Bardo; R A Bevins
Journal:  Psychopharmacology (Berl)       Date:  2000-12       Impact factor: 4.530

Review 2.  Pitfalls in the interpretation of genetic and pharmacological effects on anxiety-like behaviour in rodents.

Authors:  Jan Adriaan Bouwknecht; Richard Paylor
Journal:  Behav Pharmacol       Date:  2008-09       Impact factor: 2.293

3.  Tacr1 gene variation and neurokinin 1 receptor expression is associated with antagonist efficacy in genetically selected alcohol-preferring rats.

Authors:  Jesse R Schank; Jenica D Tapocik; Estelle Barbier; Ruslan Damadzic; Robert L Eskay; Hui Sun; Kelly E Rowe; Courtney E King; Mengdi Yao; Meghan E Flanigan; Matthew G Solomon; Camilla Karlsson; Kejun Cheng; Kenner C Rice; Markus Heilig
Journal:  Biol Psychiatry       Date:  2013-02-16       Impact factor: 13.382

4.  Predictors of ethanol consumption in adult Sprague-Dawley rats: relation to hypothalamic peptides that stimulate ethanol intake.

Authors:  Olga Karatayev; Jessica R Barson; Ambrose J Carr; Jessica Baylan; Yu-Wei Chen; Sarah F Leibowitz
Journal:  Alcohol       Date:  2010-06-18       Impact factor: 2.405

5.  Anxiety as a predictor of alcohol preference in rats?

Authors:  Barbara Langen; Heidrun Fink
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2004-09       Impact factor: 5.067

6.  Neurokinin 1 receptor antagonism as a possible therapy for alcoholism.

Authors:  David T George; Jodi Gilman; Jacqueline Hersh; Annika Thorsell; David Herion; Christopher Geyer; Xiaomei Peng; William Kielbasa; Robert Rawlings; John E Brandt; Donald R Gehlert; Johannes T Tauscher; Stephen P Hunt; Daniel Hommer; Markus Heilig
Journal:  Science       Date:  2008-02-14       Impact factor: 47.728

Review 7.  Neuronal pathways linking substance P to drug addiction and stress.

Authors:  K G Commons
Journal:  Brain Res       Date:  2009-11-11       Impact factor: 3.252

Review 8.  Involvement of substance P and the NK-1 receptor in human pathology.

Authors:  Miguel Muñoz; Rafael Coveñas
Journal:  Amino Acids       Date:  2014-04-06       Impact factor: 3.520

9.  Genetic and pharmacological antagonism of NK1 receptor prevents opiate abuse potential.

Authors:  A J Sandweiss; M I McIntosh; A Moutal; R Davidson-Knapp; J Hu; A K Giri; T Yamamoto; V J Hruby; R Khanna; T M Largent-Milnes; T W Vanderah
Journal:  Mol Psychiatry       Date:  2017-05-09       Impact factor: 15.992

10.  A prospective assessment of reports of drinking to self-medicate mood symptoms with the incidence and persistence of alcohol dependence.

Authors:  Rosa M Crum; Ramin Mojtabai; Samuel Lazareck; James M Bolton; Jennifer Robinson; Jitender Sareen; Kerry M Green; Elizabeth A Stuart; Lareina La Flair; Anika A H Alvanzo; Carla L Storr
Journal:  JAMA Psychiatry       Date:  2013-07       Impact factor: 21.596

View more
  3 in total

1.  Interleukin-4 signalling pathway underlies the anxiolytic effect induced by 3-deoxyadenosine.

Authors:  Tangxin Gao; Bai Li; Yangyang Hou; Shaolei Luo; Lei Feng; Jun Nie; Yi Ma; Le Xiao; Xu Chen; Hongkun Bao; Xianmin Lu; Feilong Huang; Gang Wang; Chunjie Xiao; Jing Du
Journal:  Psychopharmacology (Berl)       Date:  2019-04-08       Impact factor: 4.530

Review 2.  Neurokinin receptors in drug and alcohol addiction.

Authors:  Jesse R Schank
Journal:  Brain Res       Date:  2020-02-15       Impact factor: 3.252

3.  Environmental enrichment decreases chronic psychosocial stress-impaired extinction and reinstatement of ethanol conditioned place preference in C57BL/6 male mice.

Authors:  Amine Bahi; Jean-Luc Dreyer
Journal:  Psychopharmacology (Berl)       Date:  2019-11-30       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.